About University of Iowa Diagnostic Laboratories

UIDL, affiliated with UI Health Care, is a national reference laboratory offering academic expertise in specialty anatomic pathology services, advanced molecular genetic testing, and rapid renal biopsy consults. We offer very competitive turnarounds. All pathologists are available for immediate consultation by phone or email.

All of our pathologists are academic and hold professional appointments in the University of Iowa Department of Pathology, Carver College of Medicine. Each is involved in daily patient care as well as teaching in a renowned residency program and strong medical school.

Our established culture of excellent patient care is our prime objective. Emphasis is placed on practical solutions for specimen workups. The most expedient and sure method of diagnosis is utilized ensuring high quality yet cost-effective patient care.

Learn more about us

Person typing on a keyboard

Client Portal

Find information about test ordering, results, payments and other communication and coordinated care services for referring providers.

 
Various lab test packaging supplies, including boxes and envelopes

Supply Ordering for Clients

Order supplies necessary for the transport of specimens to UIDL for analysis: available to all clients. Please click the button below to begin placing your order.

Lab Samples

# 1

Ranked Hospital in Iowa

A person looking into a microscope

2.5 m

Tests performed per year

Boyd Tower with colorful trees in front of it

500 +

Tests Available

Support and Assistance

Reach out to UIDL if you have questions or concerns. We're here to help!

Support

Test Directory

Browse UIDL's test directory, containing over 500 tests.

Sending a case

Learn about various topics related to sending cases to UIDL

News

Steven Offer, PhD

Genetic Factors can Increase the Risk of a Toxic Reaction to Certain Cancer Drugs

Monday, May 6, 2024
Cancer researcher Steven Offer, PhD investigates the genetic factors that increase the risk of a toxic reaction to the cancer drug Fluorouracil (5-FU). 5-FU, used since the 1970s to treat many cancers including colorectal, stomach, breast and cervical cancer, can be toxic to certain patients. While many cancer drugs can be toxic, what sets 5-FU apart is that severe illness and death is largely preventable.
 Dr. Marco Hefti receives a five-year R01 research grant from the National Institutes of Health investigating the tau protein’s role during neurodevelopment

Dr. Marco Hefti receives a five-year R01 research grant from the National Institutes of Health investigating the tau protein’s role during neurodevelopment

Wednesday, May 1, 2024
Dr. Marco Hefti received a five-year NIH R01 award entitled “A non-canonical role for tau in early human brain development” from the National Institute of Neurological Disorders and Stroke. The award totals $561,007 and the project starts May 1, 2024 and concludes February 28, 2029.

Recent Publications

Week of June 11, 2024
Disseminated Mycobacterium chimaera infection successfully treated with a clofazimine-containing regimen and long-term follow-up after discontinuing treatment. Kobayashi T, Ford B, Diekema DJ, Sekar P. IDCases. 2024 May 22;36:e01991. doi: 10.1016/j.idcr.2024.e01991. eCollection 2024.